Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03782298
Other study ID # SMD.PEEK.RET.EXT
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 12, 2019
Est. completion date August 15, 2019

Study information

Verified date June 2020
Source Smith & Nephew, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Safety and performance of the study devices in extremities over a time period of 6 months after intervention.


Recruitment information / eligibility

Status Completed
Enrollment 122
Est. completion date August 15, 2019
Est. primary completion date August 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subjects who have undergone extremity joint repair using the study devices.

- Subjects aged 18 years and older at the time of surgery.

Exclusion Criteria:

- Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product within 12 months post-operative.

- Subjects who are < 3 months post-operative

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Spyromite, Dynomite, Raptomite, Footprint Ultra PK SL
Observational, post-market, clinical follow-up study

Locations

Country Name City State
Canada Fowler Kennedy Sport Medicine Clinic London Ontario
United States Precision Orthopaedic Specialties, Inc. Chardon Ohio
United States OrthoCarolina Charlotte North Carolina
United States Foot and Ankle Associates of North Texas-Grapevine Grapevine Texas
United States Bear Creek Surgery Center Keller Texas

Sponsors (1)

Lead Sponsor Collaborator
Smith & Nephew, Inc.

Countries where clinical trial is conducted

United States,  Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Visual Analog Scale (VAS) - pain 0 to 10 is the scoring range of pain for the joint that received treatment with the anchor 12 months
Other Range of Motion (ROM) Shoulder-full functional arc, forward flexion angle, internal, external rotation will be captured in degrees. 12 months
Primary Safety and performance of the study devices in extremities over a time period of 6 months after intervention. Clinical success is defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon. 6 months
Secondary Safety and performance of the study devices in extremities over a time period of 12 months after intervention Clinical success is defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon 12 months
See also
  Status Clinical Trial Phase
Completed NCT00609466 - A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy Phase 3
Terminated NCT00209560 - A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures Phase 3
Completed NCT00293631 - Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy Phase 2
Withdrawn NCT05087914 - Novel Non-opioid Post-surgical Pain Treatment in Females Phase 2
Completed NCT04855240 - Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy Phase 2
Completed NCT05157841 - Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy Phase 3